Filter News

Parenteral Drug Association Technical Report No. 69: Bioburden And Biofilm Management In Pharmaceutical Operations

Published: Jun 11, 2015

BETHESDA, Md., June 10, 2015 /PRNewswire-USNewswire/ -- Manufacturers of sterile drug products devote significant resources on programs to control microbial contamination in their products/processes. Bioburden and biofilm management is a significant aspect of microbial control strategies. Persistent bioburden and biofilm problems have been directly linked to several recalls and plant shutdowns.

Logo for Parenteral Drug Association.

With current scientific knowledge of microbial growth and adaptation and understanding of the causes and control of bioburden, PDA Technical Report No. 69: Bioburden and Biofilm Management in Pharmaceutical Operations has been written and organized to provide pharmaceutical professionals with all the information necessary to implement an effective and comprehensive program of bioburden and biofilm management.

Highlights

  • Provides an overview of the science of bioburden and biofilms
  • Outlines design, control and prevention considerations
  • Details all steps necessary for bioburden and biofilm detection and characterization
  • Closes the loop with a chapter on bioburden investigation and remediation

PDA Technical Report No. 69 also includes five instructive, real-life case studies.

Download/purchase the full report: https://store.pda.org/ProductCatalog/Product.aspx?ID=2789

About PDA Connecting People, Science and Regulation®

The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.

Media Inquiries: Walt Morris, 301-656-5900, x. 148; morris@pda.org

Logo - http://photos.prnewswire.com/prnh/20130226/DC66667LOGO

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pda-technical-report-no-69-bioburden-and-biofilm-management-in-pharmaceutical-operations-300097252.html

SOURCE Parenteral Drug Association

Help employers find you! Check out all the jobs and post your resume.

Back to news